Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
CERo Therapeutics Holdings, Inc. (CERO) had Free Cash Flow per Share of $-18.58 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-30.12M |
|
-- |
|
-- |
|
$4.72M |
|
$-4.72M |
|
$-0.69M |
|
$-5.42M |
|
$-5.42M |
|
$-5.42M |
|
$-5.42M |
|
$-5.42M |
|
$-5.42M |
|
$-4.72M |
|
$-4.46M |
|
0.49M |
|
0.49M |
|
$-61.71 |
|
$-61.71 |
|
| Balance Sheet Financials | |
$4.25M |
|
$0.38M |
|
$1.96M |
|
$6.20M |
|
$7.62M |
|
-- |
|
$0.22M |
|
$7.84M |
|
$-10.21M |
|
$-1.63M |
|
$-1.63M |
|
1.20M |
|
| Cash Flow Statement Financials | |
$-9.07M |
|
-- |
|
$9.04M |
|
$3.33M |
|
$3.30M |
|
$-0.02M |
|
$1.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
53.07% |
|
331.56% |
|
-87.34% |
|
331.56% |
|
$-1.37 |
|
|
Free Cash Flow per Share |
$-18.58 |
$-18.58 |
|